Glaukos (GKOS)
(Delayed Data from NYSE)
$99.48 USD
-0.63 (-0.63%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $99.49 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 37% (94 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.64 | 1.57 | 9.99 |
Current Quarter Estimate | -0.59 | 3.93 | 60.00 |
Year Ago Quarter Estimate | -0.59 | 3.85 | 52.54 |
Next Quarter Estimate | -0.52 | 3.92 | 61.00 |
Next Year Estimate | -1.36 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 3.96 | 14.60 | 17.08 |
Next Year | 37.61 | 23.10 | 8.00 |
Last 5 Years | -242.10 | 10.00 | 8.10 |
Next 5 Years | NA | 14.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 29.13 |
Price/Book (MRQ) | 10.51 | 2.25 |
Price/Cash Flow (MRFY) | NA | 15.17 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -42.79% | 7.88% |
Return on Equity (TTM) | -22.67% | 4.72% |
Debt to Equity (MRQ) | NA | 6.23 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.